Concepedia

Pallavi S. Mishra‐Kalyani

PS

34

Publications

2.2K

Citations

26

H-Index

2014

Active since

Affiliations

United States Food and Drug Administration(Current)

Center for Drug Evaluation and Research

Center for Devices and Radiological Health

Clinical Research Institute

Janssen (United States)

Pallavi S. Mishra‐Kalyani is an author at United States Food and Drug Administration specializing in medicine, oncology, and cancer therapeutics.

ORCID

Top concepts

Publications per year

2014–2024

34

Publications

34

FDA Approval Summary: Sotorasib for <i>KRAS G12C</i> -Mutated Metastatic NSCLC

Erica C. Nakajima, Nicole Drezner, Xiaoxue Li et al. · Clinical Cancer Research · 2021 · 293 citations · Full text

FDA Approval Summary: Pembrolizumab for Treatment of Metastatic Non-Small Cell Lung Cancer: First-Line Therapy and Beyond

Lee H. Pai-Scherf, Gideon M. Blumenthal, Hongshan Li et al. · The Oncologist · 2017 · 286 citations · Full text

Analysis of time-to-treatment discontinuation of targeted therapy, immunotherapy, and chemotherapy in clinical trials of patients with non-small-cell lung cancer

Gideon M. Blumenthal, Yuexuan Gong, Kenneth L. Kehl et al. · Annals of Oncology · 2019 · 151 citations

, , +10

Arm Pain in Youth Baseball Players

Eric C. Makhni, Zachary S. Morrow, Timothy J. Luchetti et al. · The American Journal of Sports Medicine · 2014 · 107 citations

FDA Approval Summary: Selumetinib for Plexiform Neurofibroma

Denise Casey, Suzanne Demko, A. K. Sinha et al. · Clinical Cancer Research · 2021 · 99 citations

Rows per page

1–5 of 34